Best in Biotech 28 Mar 2022 The Top 10 Insect-Powered Biotech Companies Insects are often seen as pests, but many species can provide new sources of food, materials, and even ways to clean up plastic waste. Here are 10 companies in this space that we think are worth watching. Many people think of insects simply as pests that eat crops and carry diseases such as malaria. While […] March 28, 2022 - 9 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 23 Mar 2022 Ilya Pharma Paves Way for Bacterial Gene Therapy with €8.5M Funding Cell and gene therapies are taking off in a big way in Europe. As the buzz grows, the Swedish firm Ilya Pharma has raised €8.5M to lay down the foundations of bacterial gene therapies for enterocolitis and diabetic ulcers. Investor interest in cell and gene therapy is ramping up fast around the world, with a […] March 23, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 22 Mar 2022 Biotechs Carve out Niches in Cystic Fibrosis Treatment Space Cystic fibrosis has proved resistant to treatments that provide long-lasting respite from the sticky mucus that affects the lungs and other organs. Emerging biotechs such as Kither Biotech as well as the old guard including Vertex are finding new ways to tackle the inherited disease. Cystic fibrosis is best known for causing thick mucus in […] March 22, 2022 - 5 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
Expert Advice 21 Mar 2022 How to Set up Manufacturing for Biotech Startups Deciding when and how to set up manufacturing can be essential to the success of any biotech startup. Experts share their advice on how to approach manufacturing decisions. Great ideas for potential biotech products, often hatched in small startup settings, seem far removed from the complexities of manufactcduring later down the line. Researchers and innovators […] March 21, 2022 - 8 minutesmins - By Matthew Williams Share WhatsApp Twitter Linkedin Email
News and Trends 17 Mar 2022 €80M Series B Establishes European Champion in Radiopharmaceuticals Big European venture capital firms Jeito, Forbion, and Inkef Capital have teamed up to propel the local radiopharmaceutical scene by investing €80M in the Belgian firm Precirix. Europe has a long history of expertise in the development of radiopharmaceutical drugs. One of the pioneers in the field was Advanced Accelerator Applications (AAA) in France. AAA […] March 17, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 15 Mar 2022 Biotech Stocks in “Total Eclipse” as Financial Pressures Mount More than a year after biotech stock indices peaked, the markets are worse than ever. Meanwhile, rumors of an impending wave of opportunistic biotech acquisitions are yet to materialize. In February of last year, biotech stocks across Europe and the US saw the end of a pandemic-fuelled growth spurt. Since then, the stock growth of […] March 15, 2022 - 6 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Opinion 14 Mar 2022 The Secrets to 50 Years of Success in Life Sciences Investment The European life sciences venture capital firm Sofinnova Partners is celebrating its 50th birthday this year. Sofinnova’s Chairman and Managing Partner, Antoine Papiernik, outlines key lessons the company has learned in its long history in the biotech industry. Meet a couple who have been married for 50 years and most of us, I imagine, would […] March 14, 2022 - 7 minutesmins - By Antoine Papiernik Share WhatsApp Twitter Linkedin Email
News and Trends 11 Mar 2022 Microbiome Space in Spotlight as Microbiotica Sets Funding Record Competition is heating up in the microbiome niche as UK-based Microbiotica raised €60M (£50M) in a Series B round to advance two candidates designed to treat cancer and ulcerative colitis. Microbiotica’s financing sets a record in Europe for microbiome specialist biotechs. The round was co-led by Sweden’s Flerie Invest and China-based Tencent, and was supported […] March 11, 2022 - 3 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
News and Trends 10 Mar 2022 Emerging Startups Take Aim at Lysosomal Storage Disorders Lysosomal storage disorders such as Niemann-Pick type C have proved difficult to tackle in the biotech industry. With recent funding rounds in the bag, Scenic Biotech and Maze Therapeutics strive to treat these conditions by activating protective genes. Lysosomal storage disorders are inherited conditions caused by mutations in metabolic enzymes found inside our cells, leading […] March 10, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 8 Mar 2022 The Top European Biotech Investments in February 2022 Companies developing lab automation, ophthalmological treatments, and novel foods received Europe’s top biotech investments in February 2022. European and Israeli biotech investments in February 2022 narrowly beat January’s performance. Life sciences companies in these regions bagged 52 private investments and initial public offerings (IPOs), worth €664M in total. Meanwhile, January’s tally was 41 deals totaling […] March 8, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 7 Mar 2022 Multiplexing Speeds up Writing and Editing DNA While scientists can read DNA fast, editing and writing it is not that easy. Increasing the speed of editing and writing DNA sequences will be critical to ushering in new applications of genome engineering. Much of biotech is about reverse-engineering the designs that billions of years of evolution have put together. To be able to […] March 7, 2022 - 6 minutesmins - By Sachin Rawat Share WhatsApp Twitter Linkedin Email
News and Trends 3 Mar 2022 Europe’s Ophthalmology Scene Stays Hot for Biotech Funding Ophthalmology-focused startups had a record year for venture capital funding in 2021. Impressive Series A rounds and collaborations hint at a continuing upward trend for the field in 2022. Biotech companies researching treatments for ophthalmological conditions experienced a splurge of venture capital (VC) funding in 2021, with the total more than trebling the haul from […] March 3, 2022 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email